Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,860,049
-$1,800,353 QoQ
Shares Held
109,079
-44.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ARQT ranks #81 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ARQT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,860,049 109,079
2026-03-31 $4,660,402 197,810
2025-12-31 $8,254,415 284,243
2025-09-30 $1,984,093 105,257
2025-06-30 $2,752,125 196,300
2025-03-31 $3,102,334 198,359
2024-12-31 $730,697 52,455
2024-09-30 $332,688 35,773
2024-06-30 $340,053 36,565
2024-03-31 $275,081 27,758
2023-12-31 $69,812 21,614
2023-09-30 $460,790 86,778
2023-06-30 $1,017,326 106,750
2023-03-31 $688,985 62,635
2022-12-31 $50,910 3,440
2022-09-30 $73,802 3,862
2022-06-30 $78,121 3,666
2022-03-31 $2,672,034 138,735
2021-12-31 $2,935,994 141,562
2021-09-30 $18,472,081 773,214
2021-06-30 $24,505,653 897,972
2021-03-31 $25,359,574 876,584
2020-12-31 $18,100,416 643,456
2020-09-30 $16,301,435 556,363
2020-06-30 $15,940,320 527,127
2020-03-31 $12,330,375 413,771